Medication comparison
Rybelsus vs Ozempic
Rybelsus and Ozempic are both prescription medications (GLP-1 receptor agonist (oral tablet) vs GLP-1 receptor agonist) used for Type 2 diabetes and Type 2 diabetes (Ozempic). The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.
Affiliate disclosure: we earn commission on signups. Editorial ranking stays independent.
This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.
Top 3 providers prescribing Rybelsus or Ozempic
See full ranking →- Best for brand-name
Ro
#1From $99.00/mo
Visit Ro LifeMD
From $249.00/mo
~3 hr· self-reportedVisit LifeMD- Best for fast start
Henry Meds
From $179.00/mo
~1.5 hr· self-reported- LegitScript
Affiliate links — we earn commission on conversions; editorial ranking is independent.
Drug A
Rybelsus
semaglutide (oral)
GLP-1 receptor agonist (oral tablet)
Novo Nordisk
See full overviewDrug B
Ozempic
semaglutide
GLP-1 receptor agonist
Novo Nordisk
See full overviewOverview
| Property | Rybelsus | Ozempic |
|---|---|---|
| Generic name | semaglutide (oral) | semaglutide |
| Drug class | GLP-1 receptor agonist (oral tablet) | GLP-1 receptor agonist |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| Brand names | Rybelsus | Ozempic, Wegovy, Rybelsus |
Approved uses
| Property | Rybelsus | Ozempic |
|---|---|---|
| Approved indications | Type 2 diabetes | Type 2 diabetes (Ozempic), Chronic weight management (Wegovy) |
Dosing
| Property | Rybelsus | Ozempic |
|---|---|---|
| Typical dosing | — | Titrate to 2.4 mg (weekly SC injection) |
Side effects & warnings
| Property | Rybelsus | Ozempic |
|---|---|---|
| Top side effects | — | Nausea (44.2%), Diarrhea (31.5%), Vomiting (24.8%) |
| Contraindications | — | — |
| Boxed warning | No | Yes |
Special populations
| Property | Rybelsus | Ozempic |
|---|---|---|
| Pregnancy | — | C — Discontinue at least 2 months before a planned pregnancy due to long half-life. |
Storage
| Property | Rybelsus | Ozempic |
|---|---|---|
| Storage | — | Refrigerate 36-46°F (2-8°C) before first use. After first use, may be stored at room temperature 59-86°F (15-30°C) for up to 56 days. Protect from light. Do not freeze. |
Cost
| Property | Rybelsus | Ozempic |
|---|---|---|
| Avg monthly cost | $1029.00 | $997.58 |
FDA boxed warning
Ozempic: Risk of thyroid C-cell tumors. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Frequently asked
What is the difference between Rybelsus and Ozempic?
Rybelsus is semaglutide (oral) (GLP-1 receptor agonist (oral tablet)) and Ozempic is semaglutide (GLP-1 receptor agonist). They have different active ingredients and slightly different side-effect profiles.
Is Rybelsus or Ozempic more effective for weight loss?
See each drug's clinical-trials section for the registrational outcome data (SURMOUNT for tirzepatide; STEP for semaglutide; SCALE for liraglutide). Average weight loss varies by trial duration, dose ceiling, and adherence.
Can I switch between Rybelsus and Ozempic?
Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide ↔ tirzepatide). Always coordinate with your prescriber before switching.
Other GLP-1 head-to-head comparisons
Compare Rybelsus or semaglutide against another GLP-1
More medication context
Tools and guides that pair with this comparison.
Overview
Rybelsus full overview
semaglutide (oral) mechanism, dosing, side effects, and pricing.
ReadOverview
Ozempic full overview
semaglutide mechanism, dosing, side effects, and pricing.
ReadLive data
GLP-1 shortage tracker
Real-time FDA shortage status by drug and dose.
ReadFree tool
Are you a candidate?
FDA-criteria decision tree, flags contraindications.
ReadFree tool
Prior auth letter generator
Payer-ready PA letter your prescriber can sign.
ReadLive data
12-month price trends
How telehealth provider pricing has moved over the past year.
Read
Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.